Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of IntegraMed America, Inc. (Nasdaq: INMD) arising from its agreement for IntegraMed to be acquired by Sagard Capital Partners, L.P., who owns 3.7% of IntegraMed’s outstanding shares, for $14.05 per share. The transaction is expected to close no later than mid-November 2012. Weiss & Lurie is investigating whether IntegraMed’s Board acted in the best interests of its shareholders in approving this deal at this time. IntegraMed recently announced that, as compared to the same quarter in 2011, during its quarter ended March 31, 2012, revenues increased 10.2% to $70.8 million, adjusted EBITDA increased 17.8% to $4.7 million, net income increased 36.6% to $1.3 million and earnings per diluted share increased 37.5% to $0.11. Indeed, IntegraMed stock surged nearly 72% to a high of $13.50 per share on April 16, 2012 since the beginning of the calendar year, when IntegraMed stock opened at $7.86 per share on January 3, 2012. The purchase price provided by Sagard under the merger agreement provides IntegraMed shareholders with a mere 4% premium to this pre-deal 52-week high. If you own IntegraMed shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Julia J. Sun, Esq. either by email at firstname.lastname@example.org or by telephone at (888) 593-4771. Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing, consumer fraud, or anti-trust violations, please email us at email@example.com or fill out the form on our website, http://www.weisslurie.com/contact/report_fraud/. Attorney Advertising. Past results do not guarantee a similar outcome.
Shares of IntegraMed America (Nasdaq:INMD) have taken a tremendous swing upward. The stock is trading at $13.71 as of 9:55 a.m. ET, 20.9% above Friday's closing price of $11.34. Volume is at 476,658, 22.5 times the daily average of 21,200.